Evidence map›Paper›PMID 39318987›Full record

ArticleJournal of vitreoretinal diseases

Update on Retinal Drug Safety: Proceedings of the ASRS ReST Committee Webinar Part 1.

Jessica M Girgis, Caroline R Baumal, Andre J Witkin, Lejla Vajzovic, Roger A Goldberg, Peter Kaiser, J Fernando Arevalo, Netan Choudhry, Eric Schneider, Homayoun Tabandeh and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of vitreoretinal diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Observational
  3. From the Editor-in-Chief.Journal of vitreoretinal diseases
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jessica M GirgisNew England Eye Center, Tufts Medicine, Boston, MA, USA.
Caroline R BaumalNew England Eye Center, Tufts Medicine, Boston, MA, USA.
Andre J WitkinNew England Eye Center, Tufts Medicine, Boston, MA, USA.ORCID https://orcid.org/0000-0002-3001-8098
Lejla VajzovicDuke Eye Center, Durham, NC, USA.
Roger A GoldbergBay Area Retina Associates, Walnut Creek, CA, USA.ORCID https://orcid.org/0000-0002-3334-5414
Peter KaiserCole Eye Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
J Fernando ArevaloWilmer Eye Institute, Baltimore, MD, USA.
Netan ChoudhryVitreous Retina Macula Specialists of Toronto, ON, Canada.
Eric SchneiderTennessee Retina, PC, Nashville, TN, USA.
Homayoun TabandehRetina-Vitreous Associates Medical Group, Beverly Hills, CA, USA.
Robert WongAustin Retina Associates, Austin, TX, USA.

Funding

Oxidative stress and innate immunity impair the visual cycleR01EY027691 · NEI · JOHNS HOPKINS UNIVERSITY · PI HANDA, JAMES T · 2017 to 2021
$2.7M
NEI NIH HHS R01 EY027691
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

amikacin toxicitybrolucizumabhemorrhagic occlusive retinal vasculitisindocyanine green toxicityintraocular inflammationocclusive vasculitispentosanpigmentary maculopathyprefilled syringevancomycin toxicity

Identifiers

PMID39318987
PMCPMC11418662

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.